Page last updated: 2024-10-26

diflunisal and Amyloidosis, Familial

diflunisal has been researched along with Amyloidosis, Familial in 1 studies

Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.

Amyloidosis, Familial: Diseases in which there is a familial pattern of AMYLOIDOSIS.

Research Excerpts

ExcerptRelevanceReference
"Diflunisal was administered orally at 500 mg/day to 40 Japanese hereditary ATTR amyloidosis patents who were not candidates for liver transplantation."2.80Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis. ( Ikeda, S; Koyama, J; Morita, H; Sekijima, Y; Tojo, K, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekijima, Y1
Tojo, K1
Morita, H1
Koyama, J1
Ikeda, S1

Trials

1 trial available for diflunisal and Amyloidosis, Familial

ArticleYear
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2015, Volume: 22, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amyloidosis, Familial; Diflunisal; Female; Hum

2015